Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: Evidence for role of MMS19L

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 4, 2009, Pages 1295-1302

  McWilliams, Robert R ^a,b   Bamlet, William R ^a   De Andrade, Mariza ^a   Rider, David N ^a   Cunningham, Julie M ^a   Petersen, Gloria M ^a  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; EXCISION REPAIR; FEMALE; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MMS19L GENE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADENOCARCINOMA; AGED; CASE-CONTROL STUDIES; DNA REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 66649091509     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-1109     Document Type: Article

References (36)

1. Thompson D, Easton DF, Breast Cancer Linkage Consortium. Cancer incidence in BRCA1 mutation carriers.[see comment]. J Natl Cancer Inst 2002;94:1358-1365 (Pubitemid 35154140)
2. The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999;91:1310-1316 (Pubitemid 29387573)
3. Petersen GM, Hruban RH. Familial pancreatic cancer: where are we in 2003?[comment]. J Natl Cancer Inst 2003;95:180-181 (Pubitemid 36240624)
4. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001;1:22-33. (Pubitemid 33741878)
5. Bootsma D, Hoeijmakers JH. The genetic basis of xeroderma pigmentosum. Ann Genet 1991;34:143-150
6. Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994;130:1018-1021
7. Kraemer KH, Lee MM, Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 1984;5:511-514 (Pubitemid 14126719)
8. de Boer J, Hoeijmakers JHJ. Nucleotide excision repair and human syndromes. Carcinogenesis 2000;21:453-460 (Pubitemid 30137930)
9. Millikan RC, Hummer A, Begg C, et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis 2006;27: 610-618 (Pubitemid 43378899)
10. Benhamou S, Sarasin A. Variability in nucleotide excision repair and cancer risk: a review. Mutat Res 2000;462:149-158 (Pubitemid 30190222)
11. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-1530 (Pubitemid 36020002)
12. Zhou W, Liu G, Miller DP, et al. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res 2002;62:1377-1381 (Pubitemid 34407795)
13. Hou SM, Falt S, Angelini S, et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002;23:599-603. (Pubitemid 34498497)
14. Mohankumar MN, Janani S, Prabhu BK, Kumar PR, Jeevanram RK. DNA damage and integrity of UV-induced DNA repair in lymphocytes of smokers analysed by the comet assay. Mutat Res 2002;520:179-187 (Pubitemid 35247587)
15. Zhao H, Wang LE, Li D, Chamberlain RM, Sturgis EM, Wei Q. Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis. Carcinogenesis 2008;29:1560-1566
16. McWilliams RR, Bamlet WR, Cunningham JM, et al. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 2008;68:4928-4935
17. Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, Evans DB, Li D. The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. Cancer Lett 2007;245:61-68 (Pubitemid 44959339)
18. Wang LD, Lu XH, Miao XP. Polymorphisms of the DNA repair genes XRCC1 and XPC: relationship to pancreatic cancer risk. Wei Sheng Yan Jiu;35:534-536
19. Duell EJ, Bracci PM, Moore JH, Burk RD, Kelsey KT, Holly EA. Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2008;17:1470-1479
20. The International HapMap Consortium. The International HapMap Project. Nature 2003;426:789-796
21. Wood RD, Mitchell M, Lindahl T. Human DNA repair genes, 2005. Mutat Res 2005;577:275-283 (Pubitemid 41225506)
22. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-120 (Pubitemid 38085242)
23. Shen R, Fan JB, Campbell D, et al. High-throughput SNP genotyping on universal bead arrays. Mutat Res 2005;573:70-82. (Pubitemid 40514402)
24. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
25. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575 (Pubitemid 47330214)
26. Gauderman WJ, Murcray C, Gilliland F, Conti DV. Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol 2007;31:383-395 (Pubitemid 47051001)
27. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-434 (Pubitemid 34112296)
28. Lake SL, Lyon H, Tantisira K, et al. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003;55:56-65. (Pubitemid 36928747)
29. Therneau T, Atkinson EJ. An introduction to recursive partitioning using the RPART routines. Technical Report Series, Section of Biostatistics, Mayo Clinic 1997. p. 61.
30. Rao DC. CAT scans, PET scans, and genomic scans. Genet Epidemiol 1998;15:1-18.
31. Lauder S, Bankmann M, Guzder SN, Sung P, Prakash L, Prakash S. Dual requirement for the yeast MMS19 gene in DNA repair and RNA polymerase II transcription. Mol Cell Biol 1996;16:6783-6793 (Pubitemid 26389737)
32. Hatfield MD, Reis AM, Obeso D, et al. Identification of MMS19 domains with distinct functions in NER and transcription. DNA Repair (Amst) 2006;5:914-924 (Pubitemid 44119249)
33. Queimado L, Rao M, Schultz RA, et al. Cloning the human and mouse MMS19 genes and functional complementation of a yeast mms19 deletion mutant. Nucleic Acids Res 2001;29:1884-1891 (Pubitemid 32433272)
34. Seroz T, Winkler GS, Auriol J, et al. Cloning of a human homolog of the yeast nucleotide excision repair gene MMS19 and interaction with transcription repair factor TFIIH via the XPBand XPD helicases. Nucleic Acids Res 2000;28:4506-4513
35. Michiels S, Danoy P, Dessen P, et al. Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. Carcinogenesis 2007;28:1731-1739 (Pubitemid 47289035)
36. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998; 316:1236-1238 (Pubitemid 28171344)